IDH Inhibitor Activity in Brain Cancer Persists With Longer Follow-Up
HOUSTON -- Progression-free survival (PFS) in IDH-mutant low-grade glioma remained twice as high in adults who received vorasidenib (Voranigo) after ...
Day: November 24, 2024
Digital Doctors Are Coming. Regulators Need to Catch Up.
Baloescu is an emergency physician, assistant professor, and AI researcher. Microsoft's new artificial intelligence (AI)-powered healthcare suite plans to "shape ...
